Clinical trial
Surveillance for Rates of Hib Disease Among Persons 0 Through 59 Months of Age Receiving Pentacel® or Other Hib Vaccines
NCT00855855 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Surveillance for Rates of Hib Disease Among Persons 0 Through 59 Months of Age Receiving Pentacel® or Other Hib Vaccines
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- December 31, 2014
- Enrollment
- 20,830 (actual)
- Sites
- 59
Conditions
As the registry lists them; a condition with its own page is linked.
diphtheria, haemophilus infections, pertussis, polio, tetanus